{"slug":"semax-postherpetic","verification":{"valid":true,"entries":2,"head":"dd9254a0772d6026a5ffc62c85c799a268b3571521e711bd62055421d7998e4b"},"energy":{"passes":2,"tokens_in":12299,"tokens_out":2499,"tokens_total":14798,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"dd9254a0772d6026a5ffc62c85c799a268b3571521e711bd62055421d7998e4b"},"provenance":[{"ts":"2026-06-30T00:04:53.140Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Postherpetic\nSlug: semax-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target othe","response":"{\n  \"slug\": \"semax-postherpetic\",\n  \"title\": \"Semax for Postherpetic Neuralgia: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\n\\nPostherpetic neuralgia (PHN) follows shingles (herpes zoster) when the varicella-zoster virus damages sensory nerves. The virus reactivates in dorsal root ganglia, causing inflammation and neuronal injury that persists after the rash clears.\\n\\nKey layers include:\\n- Peripheral nerve damage and ectopic firing in damaged sensory neurons.\\n- Central sensitization where spinal cord and brain pain pathways amplify signals.\\n- Reduced neurotrophic support as BDNF levels often decline in chronic neuropathic states.\\n- Ongoing low-grade neuroinflammation that hinders natural repair.\\n\\nIf repair pathways stay suppressed while degeneration continues, pain becomes chronic. Standard options like gabapentin or lidocaine primarily suppress symptoms rather than target underlying nerve repair.\\n\\n## Why Semax might help you\\n\\n1. **What keeps failing:** Damaged sensory nerves after shingles show reduced BDNF signaling, impaired neuronal survival, and persistent hyperexcitability.\\n2. **What Semax is studied to do:** Research in rodents shows Semax rapidly increases BDNF and NGF mRNA expression in cortex and hippocampus, supporting neuronal survival under stress and modulating neurotrophin pathways.\\n3. **Therefore for you:** If the neural repair layer is part of your PHN, Semax is discussed because it is studied for building neurotrophic support rather than masking pain signals.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural/cognitive repair layer via BDNF-related mechanisms. Any other interventions would address separate layers such as inflammation or symptom suppression.\\n\\n## What the evidence actually shows\\n\\nHuman data on Semax for PHN: none identified. No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.\\n\\nPreclinical data: Multiple rat studies demonstrate Semax in","tokens_in":12299,"tokens_out":2499,"cost":0,"prev":"genesis","hash":"9cfe70d0773c6d249c26219d80939e3252cae3269a381017b1c2a5ee62e8f3fe"},{"ts":"2026-07-17T02:41:56.904Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-postherpetic","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9cfe70d0773c6d249c26219d80939e3252cae3269a381017b1c2a5ee62e8f3fe","hash":"dd9254a0772d6026a5ffc62c85c799a268b3571521e711bd62055421d7998e4b"}]}